Market news

Detailed price information for Cibus Inc (CBUS-Q) from The Globe and Mail including charting and trades.

Download the Complete Report Here Cibus, Inc. (CBUS) Interoc Expands Rice Pipeline to Five Traits; Platform Revenue and Cost Discipline Advance as LATAM Launch Moves to 2028 Key Takeaways: Rice commercialization advanced as Interoc testing began and the relationship expanded from two to five traits, although initial LATAM launch timing moved to 2028. Sustainable Ingredients […] The post Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report appeared first

Moby summary of Cibus, Inc.'s Q2 2026 earnings call

Despite a delayed rice launch and cash runway concerns, Cibus expands partnerships and advances regulatory approvals across key markets.

Cibus (NASDAQ:CBUS) reported second-quarter 2026 revenue of $1.0 million, compared with $0.9 million a year earlier, as the agricultural biotechnology company advanced its Sustainable Ingredients program and updated the expected timing of its initial rice launch in Latin America. For the first six

Cibus (CBUS) delivered earnings and revenue surprises of -11.54% and -29.50%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Commercialization execution advances in Rice and Sustainable Ingredients United States and European Union now aligned on generally treating crops with no added foreign DNA as conventionally bred Quarterly net cash usage declined 19% sequentially and 31% year over year SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a technology company that uses biology to produce sustainable ingredients and helps farmers grow more food with fewer inputs, today announced

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

SAN DIEGO, July 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a technology company that helps farmers grow more food with fewer inputs, today announced that the company will report second quarter 2026 financial results on Thursday, August 13, 2026. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Second Quarter 2026 Results Conference Call Event Date: Thursday

Download the Complete Report Here Cibus, Inc. (CBUS) Rice Royalty Conversion, Precision-Breeding Platform, and BioFragrance Scale-Up Support Commercial Inflection CBUS is an asset-light precision-breeding platform that develops productivity traits for seed-company partners, rather than owning seed production, distribution or farmer relationships. RTDS and the Trait Machine process are designed to edit elite customer germplasm and […] The post Cibus Inc’s Precision-Breeding Platform and BioFragra

Cibus, Inc. (CBUS) Rice Royalty Conversion, Precision-Breeding Platform, and BioFragrance Scale-Up Support Commercial Inflection Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com karenr@capmarketsmedia.com The post Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report appeared first on ExecEdge.

Cibus Real Estate AB (publ) (FRA:6N5) reports a robust quarter with a 15% increase in net operating income and strategic expansion through property acquisitions valued at EUR 107 million.

Cibus, Inc. (NASDAQ:CBUS) is one of the 10 Fastest Growing Tech Penny Stocks to Buy. On June 17, 2026, Cibus, Inc. (NASDAQ:CBUS) welcomed a landmark European Union decision under which crops improved without adding foreign DNA will be treated like conventionally bred crops rather than transgenic GMOs. Cibus said the decision opens a path for […]